Neurocrine Biosciences Inc
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 24,788 | 0.0% | 174,774 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 24,647 | 0.0% | 175,574 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 21,967 | 0.0% | 174,774 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 19,330 | 0.0% | 174,774 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 24,266 | 0.0% | 177,774 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 20,714 | 0.0% | 179,774 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 28,691 | 0.0% | 208,407 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 28,462 | 0.0% | 206,368 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 28,249 | 0.0% | 214,396 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 27,433 | 0.0% | 243,852 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 20,115 | 0.0% | 213,313 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 20,696 | 0.0% | 204,469 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 27,500 | 0.0% | 230,239 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 29,102 | 0.0% | 274,000 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 24,447 | 0.0% | 250,787 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 22,925 | 0.0% | 244,536 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 18,146 | 0.0% | 213,057 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 20,245 | 0.0% | 211,080 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 24,387 | 0.0% | 250,586 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 24,604 | 0.0% | 252,997 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 25,238 | 0.0% | 263,306 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 21,662 | 0.0% | 225,271 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 22,168 | 0.0% | 181,708 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 16,557 | 0.0% | 191,295 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 20,643 | 0.0% | 192,050 | 12/31/2019 |